Research

Hetero prides itself for being one of the fewpharmaceutical organisations that thrives on a robustResearch and Development program. In fact, it is themainstay of our continued success. We startedinvesting in R&D as early as 1995, which gave us ahead start for developing an expansive basket ofproducts to meet diverse market requirements acrossthe globe. Also, our extensive focus on R&D helped ustranscend API & Formulation research to successfullyexpand our capabilities into therealm of Biosimilars.


Spearheaded by more than 500 top-notch scientists,our R&D team excels at developing generics, difficult-to-make & complex APIs (Active PharmaceuticalIngredients), formulations, Novel Drug DeliverySystems (NDDS), New Chemical Entities (NCEs) andBiosimilar products besidesconsistently evolving witha sustainable pipeline of products.